/ALDVI.PA
ALDVI.PA Stock - Advicenne S.A.
Healthcare|BiotechnologyPAR
$1.75-0.45%
$0.01 (-0.45%) • Dec 23
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.70
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.93
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALDVI.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.73 – $1.77
TARGET (TP)$2.01
STOP LOSS$1.61
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.91
52W High$2.20
52W Low$1.10
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.97M | $4.46M | $2.40M | $2.69M | $2.06M |
| Gross Profit | $-1,176,000 | $-6,308,000 | $1.28M | $1.72M | $1.18M |
| Gross Margin | -23.6% | -141.5% | 53.4% | 63.8% | 57.0% |
| Operating Income | $-9,059,000 | $-6,457,000 | $-10,059,000 | $-12,443,000 | $-14,135,000 |
| Net Income | $-6,464,000 | $-7,031,000 | $-11,471,000 | $-12,427,000 | $-14,846,000 |
| Net Margin | -130.0% | -157.7% | -478.6% | -462.1% | -720.0% |
| EPS | $-0.53 | $-0.67 | $-1.13 | $-1.31 | $-1.69 |
Company Overview
Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALDVI.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.40
Q3 2025
EPS Surprise History
Q1 22
No data
Q3 22
No data
Q1 23
No data
Q3 23
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 19, 2025 | — | $-0.40 | — | — |
Q1 2025 | Mar 27, 2025 | — | $-0.08 | — | — |
Q3 2024 | Sep 18, 2024 | — | $-0.45 | — | — |
Q2 2024 | May 21, 2024 | — | $-0.30 | — | — |
Q3 2023 | Sep 11, 2023 | — | $-0.37 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.66 | — | — |
Q3 2022 | Sep 21, 2022 | — | $-0.48 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.44 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-0.91 | — | — |
Q2 2021 | Apr 29, 2021 | — | $-0.82 | — | — |
Q4 2020 | Dec 24, 2020 | — | $-0.90 | — | — |
Q1 2020 | Mar 13, 2020 | — | $-0.90 | — | — |
Q3 2019 | Sep 23, 2019 | — | $-0.83 | — | — |
Q1 2019 | Mar 21, 2019 | — | $-0.11 | — | — |
Q3 2018 | Sep 20, 2018 | — | $-0.47 | — | — |
Q2 2018 | Apr 10, 2018 | — | $-0.56 | — | — |
Q4 2017 | Nov 22, 2017 | — | $-0.43 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.44 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.48 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.30 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALDVI.PA
What is ALDVI.PA's current stock price?
Advicenne S.A. (ALDVI.PA) is currently trading at $1.75 per share. The stock has moved -0.45% today.
What is the analyst price target for ALDVI.PA?
No analyst price targets are currently available for this stock.
What sector is Advicenne S.A. in?
Advicenne S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the PAR exchange.
What is ALDVI.PA's market cap?
Advicenne S.A. has a market capitalization of $0.03 billion, making it a small-cap company.
Does ALDVI.PA pay dividends?
No, Advicenne S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAELIS.PA
Aelis Farma S.A.
$1.07
Mkt Cap: $0.0B
ALCOX.PA
Nicox S.A.
$0.29
Mkt Cap: $0.0B
ALGEN.PA
genOway S.A.
$2.60
Mkt Cap: $0.0B
ALIKO.PA
Ikonisys S.A.
$1.64
Mkt Cap: $0.0B
ALNFL.PA
NFL Biosciences S.A.
$1.16
Mkt Cap: $0.0B
ALTHX.PA
THX Pharma
$2.02
Mkt Cap: $0.0B
ALVAL.PA
Valbiotis S.A.
$0.69
Mkt Cap: $0.0B
ALVIO.PA
Valerio Therapeutics S.A.
$0.11
Mkt Cap: $0.0B
POXEL.PA
Poxel S.A.
$0.24
Mkt Cap: $0.0B
SIGHT.PA
GenSight Biologics S.A.
$0.11
Mkt Cap: $0.0B
Explore stocks similar to ALDVI.PA for comparison